With the latest well-tolerated pangenotypic direct acting antivirals (DAAs) (sofosbuvir/velpatasvir or glecaprevir/pibrentasvir) [2, 3], treatment duration decreased to 812 weeks, treatment success increased to 95100% and genotyping became dispensable [4]
Over the past decade the dysmetabolic state of insulin resistance (IR) and its correlate, compensatory hyperinsulinemia, have been considered important additional aspects
By taking up space, it makes you feel full so you eat less
Because of this dual action, tirzepatide may produce different results and is often recommended for patients with more complex metabolic needs
In many instances, medications don't achieve the efficacy of weight loss surgery, William Fuller, MD, a bariatric surgeon at Scripps Clinic